國立虎尾科技大學 |

Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics/ edited by Erika Ruiz-Garcia, Horacio Astudillo-de la Vega.
other author:	Ruiz-Garcia, Erika.
Description:	X, 171 p. 19 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Molecular biology. -
Online resource:	https://doi.org/10.1007/978-3-030-24100-1
ISBN:	9783030241001

Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics
Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics[electronic resource] /edited by Erika Ruiz-Garcia, Horacio Astudillo-de la Vega. - 1st ed. 2019. - X, 171 p. 19 illus. in color.online resource. - Advances in Experimental Medicine and Biology,11680065-2598 ;. - Advances in Experimental Medicine and Biology,889.

Preface -- Pharmaco-Geno-Proteo-Metabolomics and Translational Research in Cancer -- Next generation sequencing (NGS): a revolutionary technology in pharmacogenomics and personalized medicine in Cancer -- Pharmaco-epigenomics: on the road of translation medicine -- Design and Implementing Pharmacogenomics Study in Cancer -- Onco-omics approaches and applications in Clinical Trials for Cancer patients -- Issues and Ethical Considerations in Pharmaco-oncogenomics -- Pharma-oncogenomics in the era of personal genomics: a quick guide to online resources and tools -- Inmuno-Oncology in the era of Personalized Medicine -- CAR T Cell and Personalized Medicine -- Oncobiome at the forefront of a novel molecular mechanism to understand the Microbiome and Cancer -- Nutrition, Cancer and Personalized Medicine -- Index.

This book presents concise chapters written by internationally respected experts on various important aspects of translational cancer genomics, offering a comprehensive overview of the onco-omics applications in the new era of cancer personal genomics research field. Being a complex disease that affects millions of people worldwide, cancer research has assumed great significance. Translational cancer research transforms scientific discoveries in the laboratory into clinical application to reduce incidence of cancer, morbidity and mortality. In the other hand, personalized medicine in cancer is the concept that selection of a treatment should be tailored according to the individual patient’s specific genomic characteristics, including mutations, chromosomal aberrations, protein interactions, and even more, considering the immune system, the metabolism and in the near future the microbiome, all areas nowadays related in the prognosis and treatment of cancer patients. These contributions are either critical reviews or clinical and basic research reports. The topics discussed here include evidence-based medicine and provides useful information on translational cancer research to clinicians and biomedical scientists in order to offer another vision of cancer origin beyond the traditional causes or the oncogenic maintenance concept proposed by the oncogene addiction theory.

ISBN: 9783030241001

Standard No.: 10.1007/978-3-030-24100-1doiSubjects--Topical Terms:

583443
Molecular biology.

LC Class. No.: QH506

Dewey Class. No.: 611.01816

Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics
LDR:03748nam a22004215i 4500 001 1006272
003 DE-He213
005 20200704152519.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030241001 $9 978-3-030-24100-1
024 7 $a 10.1007/978-3-030-24100-1 $2 doi
035 $a 978-3-030-24100-1
050 4 $a QH506
072 7 $a MBGR $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a MBGR $2 thema
072 7 $a PSD $2 thema
082 0 4 $a 611.01816 $2 23
245 1 0 $a Translational Research and Onco-Omics Applications in the Era of Cancer Personal Genomics $h [electronic resource] / $c edited by Erika Ruiz-Garcia, Horacio Astudillo-de la Vega.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a X, 171 p. 19 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Advances in Experimental Medicine and Biology, $x 0065-2598 ; $v 1168
505 0 $a Preface -- Pharmaco-Geno-Proteo-Metabolomics and Translational Research in Cancer -- Next generation sequencing (NGS): a revolutionary technology in pharmacogenomics and personalized medicine in Cancer -- Pharmaco-epigenomics: on the road of translation medicine -- Design and Implementing Pharmacogenomics Study in Cancer -- Onco-omics approaches and applications in Clinical Trials for Cancer patients -- Issues and Ethical Considerations in Pharmaco-oncogenomics -- Pharma-oncogenomics in the era of personal genomics: a quick guide to online resources and tools -- Inmuno-Oncology in the era of Personalized Medicine -- CAR T Cell and Personalized Medicine -- Oncobiome at the forefront of a novel molecular mechanism to understand the Microbiome and Cancer -- Nutrition, Cancer and Personalized Medicine -- Index.
520 $a This book presents concise chapters written by internationally respected experts on various important aspects of translational cancer genomics, offering a comprehensive overview of the onco-omics applications in the new era of cancer personal genomics research field. Being a complex disease that affects millions of people worldwide, cancer research has assumed great significance. Translational cancer research transforms scientific discoveries in the laboratory into clinical application to reduce incidence of cancer, morbidity and mortality. In the other hand, personalized medicine in cancer is the concept that selection of a treatment should be tailored according to the individual patient’s specific genomic characteristics, including mutations, chromosomal aberrations, protein interactions, and even more, considering the immune system, the metabolism and in the near future the microbiome, all areas nowadays related in the prognosis and treatment of cancer patients. These contributions are either critical reviews or clinical and basic research reports. The topics discussed here include evidence-based medicine and provides useful information on translational cancer research to clinicians and biomedical scientists in order to offer another vision of cancer origin beyond the traditional causes or the oncogenic maintenance concept proposed by the oncogene addiction theory.
650 0 $a Molecular biology. $3 583443
650 0 $a Cancer research. $3 1253664
650 0 $a Pharmaceutical technology. $3 557391
650 0 $a Immunology. $3 592892
650 0 $a Biomedical engineering. $3 588770
650 0 $a Genetics. $3 578972
650 1 4 $a Molecular Medicine. $3 668353
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 2 4 $a Biomedical Engineering/Biotechnology. $3 1068811
650 2 4 $a Genetics and Genomics. $3 1229010
700 1 $a Ruiz-Garcia, Erika. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1299790
700 1 $a Astudillo-de la Vega, Horacio. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1299791
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030240998
776 0 8 $i Printed edition: $z 9783030241018
776 0 8 $i Printed edition: $z 9783030241025
830 0 $a Advances in Experimental Medicine and Biology, $x 0065-2598 ; $v 889 $3 1253792
856 4 0 $u https://doi.org/10.1007/978-3-030-24100-1
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)